| Dr Hardeep Singh Dhindsa, MD | |
|
5449 Reno Corporate Dr Ste 200, Reno, NV 89511-2626 | |
| (775) 737-9411 | |
| (775) 737-9413 |
| Full Name | Dr Hardeep Singh Dhindsa |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 5449 Reno Corporate Dr Ste 200, Reno, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366402570 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | C51013 (California) | Secondary |
| 207W00000X | Ophthalmology | H4282 (Texas) | Secondary |
| 207W00000X | Ophthalmology | 10317 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northern Nevada Medical Center | Sparks, NV | Hospital |
| Renown Regional Medical Center | Reno, NV | Hospital |
| Entity Name | H Dhindsa Retina Eye Center, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568740751 PECOS PAC ID: 5294906137 Enrollment ID: O20110926000272 |
News Archive
Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells.
A new study has found impaired blood vessel function in those living with human immunodeficiency virus (HIV).
A Purdue physicist has created technology to detect motion inside three-dimensional tumor spheroids, which may enhance the pharmaceutical industry's early drug discovery capabilities.
Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few. According to a study published today in the journal Cell, researchers have discovered a tool that can monitor related damage and determine the degree to which antioxidant drugs effectively combat disease.
In the setting of potentially reduced vaccine efficacy against coronavirus disease (COVID-19) due to emerging viral variants, the deployment of effective treatments based on monoclonal antibodies may be an additional strategy to help control the pandemic. A new study by US researchers, currently available on the bioRxiv* preprint server, describes the action of a specific antibody known as DH1047.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hardeep Singh Dhindsa, MD 5449 Reno Corporate Dr Ste 200, Reno, NV 89511-2626 Ph: (775) 737-9411 | Dr Hardeep Singh Dhindsa, MD 5449 Reno Corporate Dr Ste 200, Reno, NV 89511-2626 Ph: (775) 737-9411 |
News Archive
Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells.
A new study has found impaired blood vessel function in those living with human immunodeficiency virus (HIV).
A Purdue physicist has created technology to detect motion inside three-dimensional tumor spheroids, which may enhance the pharmaceutical industry's early drug discovery capabilities.
Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few. According to a study published today in the journal Cell, researchers have discovered a tool that can monitor related damage and determine the degree to which antioxidant drugs effectively combat disease.
In the setting of potentially reduced vaccine efficacy against coronavirus disease (COVID-19) due to emerging viral variants, the deployment of effective treatments based on monoclonal antibodies may be an additional strategy to help control the pandemic. A new study by US researchers, currently available on the bioRxiv* preprint server, describes the action of a specific antibody known as DH1047.
› Verified 2 days ago
David B Chaffin, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5420 Kietzke Ln, Ste 103, Reno, NV 89511 Phone: 775-329-2300 Fax: 775-329-5514 | |
Geoffrey Cecchi, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 950 Ryland St, Reno, NV 89502 Phone: 775-329-0286 Fax: 775-329-4243 | |
Elena Geraymovych, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 610 Sierra Rose Dr, Reno, NV 89511 Phone: 775-356-7272 Fax: 775-356-2922 | |
Shane Williamson, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 5053 S Mccarran Blvd, Reno, NV 89502 Phone: 775-853-2000 | |
Mr. Kevin Michael Gamett, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5510 Reno Corporate Dr, Reno, NV 89511 Phone: 775-622-9078 Fax: 775-622-0696 | |
Barbara A Irish, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5420 Kietzke Ln, Ste 103, Reno, NV 89511 Phone: 775-329-2300 Fax: 775-329-5514 | |
Dr. Marcus Juen Yue Ko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5435 Reno Corporate Dr Ste 100, Reno, NV 89511 Phone: 775-322-3111 Fax: 775-322-8388 |